CORC

在结果中检索

CORC

浏览/检索结果: 共39条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Comparison among driving state prediction models for car-following condition based on EEG and driving features 期刊论文
Accident Analysis and Prevention, 2019, 卷号: 133
作者:  Yang, Liu;  Guan, Wei;  Ma, Rui;  Li, Xiaomeng
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
Highly fluorescent Ti3C2 MXene quantum dots for macrophage labeling and Cu2+ ion sensing 期刊论文
Nanoscale, 2019, 卷号: 11, 期号: 30
作者:  Guan, Qingwen;  Ma, Junfei;  Yang, Wenjing;  Zhang, Rui;  Zhang, Xiaojie
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/05
Chromosome level comparative analysis of Brassica genomes 期刊论文
PLANT MOLECULAR BIOLOGY, 2019, 卷号: 99, 期号: 3
作者:  Wang, Wenliang;  Guan, Rui;  Liu, Xing;  Zhang, Haorui;  Song, Bo
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Stretchable Transparent Conductors: from Micro/Macromechanics to Applications 期刊论文
Advanced Materials, 2019, 卷号: 31, 期号: 35
作者:  Chen, Zhi Hong;  Fang, Rui;  Li, Wei;  Guan, Jianguo
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
3D-Printed MOF-Derived Hierarchically Porous Frameworks for Practical High-Energy Density Li–O2 Batteries 期刊论文
Advanced Functional Materials, 2019, 卷号: 29, 期号: 1
作者:  Lyu, Zhiyang;  Lim, Gwendolyn J. H.;  Guo, Rui;  Kou, Zongkui;  Wang, Tingting
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace